Literature DB >> 3020440

Increased sensitivity to alpha-adrenoceptor stimulation but intact purinergic and muscarinergic effects in prehypertensive cardiac hypertrophy of spontaneously hypertensive rats.

M Böhm, U Mende, W Schmitz, H Scholz.   

Abstract

The effects of phenylephrine, isoprenaline and adenosine, (-)-N6-phenylisopropyladenosine (PIA) or carbachol alone and in the presence of isoprenaline on force of contraction were studied in isolated electrically driven papillary muscles of spontaneously hypertensive rats (SHR) and age-matched Wistar control rats. In SHR an increased heart to body weight ratio was observed when blood pressure was not yet elevated. During this stage of the syndrome (i.e. between the 27th and 35th day of life) phenylephrine was about 3.4 times more potent to increase force of contraction in SHR (mean EC50: 2.8 mumol l-1) than in control rats (mean EC50: 9.4 mumol l-1). The positive inotropic effect of isoprenaline was similar in SHR and control rats. Also no difference could be detected in the isoprenaline-antagonistic effect of adenosine, the adenosine receptor agonist PIA or carbachol. We conclude that an increased sensitivity to cardiac alpha-adrenoceptor stimulation might be related to prehypertensive cardiac hypertrophy in SHR.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3020440     DOI: 10.1007/bf00512942

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  29 in total

1.  Epinephrine elevation in plasma parallels canine cardiac hypertrophy.

Authors:  J R Womble; M K Haddox; D H Russell
Journal:  Life Sci       Date:  1978-11-09       Impact factor: 5.037

2.  Adenosine as inhibitor of myocardial effects of catecholamines.

Authors:  J Schrader; G Baumann; E Gerlach
Journal:  Pflugers Arch       Date:  1977-11-25       Impact factor: 3.657

3.  Cardiac hypertrophy in spontaneously hypertensive rats.

Authors:  S Sen; R C Tarazi; P A Khairallah; F M Bumpus
Journal:  Circ Res       Date:  1974-11       Impact factor: 17.367

4.  Regression of cardiac hypertrophy after therapy in animal hypertension.

Authors:  W Motz; B E Strauer
Journal:  J Cardiovasc Pharmacol       Date:  1985       Impact factor: 3.105

5.  Development of SHR hypertension and cardiac hypertrophy during prolonged beta blockade.

Authors:  M A Pfeffer; J M Pfeffer; A K Weiss; E D Frohlich
Journal:  Am J Physiol       Date:  1977-06

Review 6.  Pharmacologic regression of cardiac hypertrophy in experimental hypertension.

Authors:  M A Pfeffer; J M Pfeffer
Journal:  J Cardiovasc Pharmacol       Date:  1984       Impact factor: 3.105

7.  Adenosine inhibition of catecholamine-induced increase in force of contraction in guinea-pig atrial and ventricular heart preparations. Evidence against a cyclic AMP- and cyclic GMP-dependent effect.

Authors:  M Böhm; R Brückner; I Hackbarth; B Haubitz; R Linhart; W Meyer; B Schmidt; W Schmitz; H Scholz
Journal:  J Pharmacol Exp Ther       Date:  1984-08       Impact factor: 4.030

8.  Norepinephrine-stimulated hypertrophy of cultured rat myocardial cells is an alpha 1 adrenergic response.

Authors:  P Simpson
Journal:  J Clin Invest       Date:  1983-08       Impact factor: 14.808

9.  Cardiac hypertrophy and antihypertensive therapy.

Authors:  S Sen; R C Tarazi; F M Bumpus
Journal:  Cardiovasc Res       Date:  1977-09       Impact factor: 10.787

10.  Development of left ventricular hypertrophy in young spontaneously hypertensive rats after peripheral sympathectomy.

Authors:  A F Cutilletta; L Erinoff; A Heller; J Low; S Oparil
Journal:  Circ Res       Date:  1977-04       Impact factor: 17.367

View more
  2 in total

1.  [Cardiac effects of adenosine. Mechanism of action, pathophysiologic and clinical significance].

Authors:  M Böhm
Journal:  Klin Wochenschr       Date:  1987-06-01

2.  Properties of cardiac alpha- and beta-adrenoceptors in spontaneously hypertensive rats.

Authors:  M Böhm; D Beuckelmann; F Diet; G Feiler; M J Lohse; E Erdmann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-10       Impact factor: 3.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.